PHARMACEUTICAL

Displaying 10 out of 11 results

Commentary

Commentary: Glaring vaccine gaps across the world are too big to ignore

Many hoped the pandemic would end proprietary science and patent-based market monopolies. That hope has since faded, says Kaushik Basu.
Business

EU regulators team up with US and UK on pharmaceutical mergers

EU antitrust enforcers have teamed up with their U.S. and British counterparts to share expertise on how to examine mergers in the pharmaceutical ...
Media playtime

22:50minutes
In Conversation 2020/2021

Ep 14: Ryan Richardson, Chief Strategy Officer, BioNTech
Countries worldwide are rushing to approve Covid-19 vaccines. In Conversation’s Lin Xueling asks leading vaccine maker BioNTech – how safe is it?
Media playtime

23:02minutes
Wizards Of Tech

Ep 1: Wizards Of Tech: Body
An anime fan 3D-printing bespoke pills that render complicated dosage a thing of the past. A Star Wars geek turning sci-fi into reality with his ...
Media playtime

47:40minutes
Ep 12: Survivorship
The top killers - prostate, colorectal, lung and breast cancers are also the ones with the highest survivor rates. Life is an uphill battle after ...
Media playtime

12:32minutes
Money Mind 2020/2021

Podcast: 5 Things About Vaccine Stocks
The heat is on to find a vaccine for the Covid-19 disease. Biotech and pharmaceutical firms leading the vaccine race have come under the spotlight ...
Diversity At Work

Making a global impact by embracing diversity

Overseeing seven international manufacturing plants at GSK, Ms Yong Hwee Yee is driving the pharmaceuticals industry to new heights, and improving ...
Singapore

Pharmaceutical firm GSK launches new facilities to speed up medicine production
Related contents' playtime

02:00minutes
Business

Drugmaker GlaxoSmithKline's profit boosted by Trump's reforms
Business

Drug maker Bristol-Myers Squibb to buy Celgene in US$74b deal